skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All


Show More


Show More

Show More


Show More

Show More

47 Total results for product and free and sample content found

Pink Sheet

Vaccine Distribution Priorities To Rely On Governors, Not ACIP, HHS Secretary Azar Says

By Derrick Gingery 29 Nov 2020

covid19 vaccines distribution

Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated

Topic Vaccines Coronavirus Distribution

HBW Insight

UK Researchers Seek Commercial Partner For Nasal Spray Shown To 'Prevent' COVID-19

By Tom Gallen 29 Nov 2020

covid19 nasal spray R&D

A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.

Topic Coronavirus Research & Development Vaccines OTC Drugs


Quick Listen: Scrip's Five Must-Know Things

By Ian Haydock 29 Nov 2020

Scrip August Podcast

Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things

Topic Coronavirus Research & Development Vaccines


Russia Prepares $10 COVID-19 Vaccine For International Launch

By Andrew McConaghie 29 Nov 2020

covid19 russian vaccine

Russia is promising the best of both worlds – a low price with a near-perfect efficacy. While the basic science is plausible, its best-in-class claims are bound to generate skepticism

Topic Coronavirus Vaccines


Oxford/AZ's COVID-19 Vaccine Cuts Virus Spread By 60%

By Vibha Sharma 29 Nov 2020

Covid19 Vaccine oxfordAZ

Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.

Topic Coronavirus Vaccines

Pink Sheet

For Coronavirus US FDA Is At The Podium But Not On The Task Force

By Derrick Gingery 27 Nov 2020

Hahn speaks at Coronavirus briefing

The FDA is curiously not one of the HHS entities coordinating the US response to the outbreak, but must monitor for manufacturing disruptions and shortages, as well as approve new treatments and diagnostics.

Topic FDA Vaccines Infectious Diseases Coronavirus

In Vivo

COVID-19 Vaccine Expectations Are Ambitious Not Impossible

By Lucie Ellis 27 Nov 2020

invivo-COVID-19 Vaccine Expectations Are Ambitious Not Impossible

Johan Van Hoof, global head of vaccines at Janssen, talks to In Vivo about the company’s platform, how it is approaching COVID-19 research and the impact of today’s global pandemic on the future of vaccine R&D.

Topic Coronavirus Vaccines

Pink Sheet

COVID-19 Vaccine Advisory Committee May Help Determine US FDA Approach To Licensure

By Brenda Sandburg 27 Nov 2020

Covid19 vaccine pink sheet

The October panel will not review a specific application, but is expected to offer FDA advice on whether emergency use authorization is an appropriate pathway for COVID vaccines, and what data would be needed for full licensure. Sponsors may present data on their candidate vaccines.

Topic Coronavirus Vaccines


Coronavirus Update: Moderna In Advanced Talks With Europe On Vaccine Supplies

By Scrip Team 27 Nov 2020

Moderna Talks To Europe ON Vaccine Supplies Covid19

The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.

Topic Coronavirus Clinical Trials Vaccines

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is ready to hear from you for a particular request or area of interest. Please do not hesitate to reach out and discuss.

Contact us for product technical and account support.

  • US Toll-Free   : +1 888 670 8900 
  • US Toll             : +1 212-600-3520
  • UK & Europe : +44 (0) 208 052 0700

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: